TECH Bio-Techne Corp

$59.38

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About Bio-Techne Corp

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.

Website: https://www.bio-techne.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
June
CIK
842023
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN, US
Valuation
Market Cap
$7.60B
P/E Ratio
49.08
PEG Ratio
1.01
Price to Book
3.66
Performance
EPS
$0.98
Dividend Yield
0.67%
Profit Margin
13.20%
ROE
7.83%
Technicals
50D MA
$60.47
200D MA
$70.91
52W High
$85.29
52W Low
$46.44
Fundamentals
Shares Outstanding
158M
Target Price
$79.69
Beta
1.45

TECH EPS Estimates vs Actual

● Estimated
● Actual

TECH News & Sentiment

Nov 06, 2025 • Motley Fool SOMEWHAT-BULLISH
Bio-Techne ( TECH ) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.Nov. 5, 2025, 9:00 a.m. ETPresident and Chief Executive Officer - Kim KeldermanContinue reading ...
Nov 05, 2025 • Zacks Commentary NEUTRAL
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
Oct 23, 2025 • Zacks Commentary NEUTRAL
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
TECH's Q1 results could reflect steady Protein Sciences growth but pressure in Spatial Biology amid NIH and biotech funding uncertainty.
Oct 23, 2025 • Benzinga BULLISH
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital - Bio-Techne ( NASDAQ:TECH )
ST. PAUL, Minn., Oct. 23, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation ( NASDAQ:TECH ) and CellReady, announced four G-Rex Grants have been awarded to faculty members at Children's National Hospital.
Oct 08, 2025 • Benzinga BULLISH
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL,, Oct. 08, 2025 ( GLOBE NEWSWIRE ) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for market leaders, particularly as demand for international collaboration and sample sharing ...
Oct 08, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Sentiment Snapshot

Average Sentiment Score:

0.215
50 articles with scored sentiment

Overall Sentiment:

Bullish

TECH Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
0.03 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.50
  • Whisper: —
  • Surprise %: 6.0%
May 07, 2025
Mar 31, 2025 (Pre market)
0.05 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: 9.8%
Feb 05, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.42
  • Estimate: $0.39
  • Whisper: —
  • Surprise %: 7.7%
Oct 30, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.42
  • Estimate: $0.38
  • Whisper: —
  • Surprise %: 10.5%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.49
  • Whisper: —
  • Surprise %: 0.0%
May 01, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.48
  • Estimate: $0.45
  • Whisper: —
  • Surprise %: 6.7%
Feb 01, 2024
Dec 31, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.40
  • Estimate: $0.41
  • Whisper: —
  • Surprise %: -2.4%
Oct 31, 2023
Sep 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.44
  • Whisper: —
  • Surprise %: -6.8%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.55
  • Whisper: —
  • Surprise %: 0.0%

Financials